Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Collins

Showing results (81-90 of 160) with videos related to

Pageof 16
Sort By:
Virology|April 25, 2000
Mutational analysis of the bovine respiratory syncytial virus nucleocapsid protein using a minigenome system: mutations that affect encapsidation, RNA synthesis, and interaction with the phosphoproteinS K Khattar, A S Yunus, P L Collins, et al.
The Journal of Biological Chemistry|August 8, 1997
Hypotonic stress increases cyclooxygenase-2 expression and prostaglandin release from amnion-derived WISH cellsD W Lundgren, R M Moore, P L Collins, et al.
Virology|July 21, 1997
Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of sixA P Durbin, J W Siew, B R Murphy, et al.
Virology|August 26, 1998
A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypesS S Whitehead, C Y Firestone, P L Collins, et al.
Virology|May 5, 2001
RhoA is activated during respiratory syncytial virus infectionT L Gower, M E Peeples, P L Collins, et al.
Journal of Virology|April 20, 2001
Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3A C Schmidt, J M McAuliffe, B R Murphy, et al.
Journal of Virology|September 1, 1982
Coding assignments of the five smaller mRNAs of Newcastle disease virusP L Collins, G W Wertz, L A Ball, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteinsP R Johnson, M K Spriggs, R A Olmsted, et al.
Journal of Virology|July 11, 2000
Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokinesA Bukreyev, S S Whitehead, C Prussin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicityA Bukreyev, S S Whitehead, N Bukreyeva, et al.
Pageof 16

Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Virology|April 25, 2000
Mutational analysis of the bovine respiratory syncytial virus nucleocapsid protein using a minigenome system: mutations that affect encapsidation, RNA synthesis, and interaction with the phosphoproteinS K Khattar, A S Yunus, P L Collins, et al.
The Journal of Biological Chemistry|August 8, 1997
Hypotonic stress increases cyclooxygenase-2 expression and prostaglandin release from amnion-derived WISH cellsD W Lundgren, R M Moore, P L Collins, et al.
Virology|July 21, 1997
Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of sixA P Durbin, J W Siew, B R Murphy, et al.
Virology|August 26, 1998
A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypesS S Whitehead, C Y Firestone, P L Collins, et al.
Virology|May 5, 2001
RhoA is activated during respiratory syncytial virus infectionT L Gower, M E Peeples, P L Collins, et al.
Journal of Virology|April 20, 2001
Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3A C Schmidt, J M McAuliffe, B R Murphy, et al.
Journal of Virology|September 1, 1982
Coding assignments of the five smaller mRNAs of Newcastle disease virusP L Collins, G W Wertz, L A Ball, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteinsP R Johnson, M K Spriggs, R A Olmsted, et al.
Journal of Virology|July 11, 2000
Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokinesA Bukreyev, S S Whitehead, C Prussin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicityA Bukreyev, S S Whitehead, N Bukreyeva, et al.
Pageof 16